SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+30.99%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.19B
AUM Growth
+$2.19B
(+18%)
Cap. Flow
-$50.9M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
47.59%
Holding
101
New
13
Increased
23
Reduced
21
Closed
13
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$69.2M |
| 2 |
Goldman Sachs
GS
|
$42.6M |
| 3 |
TSMC
TSM
|
$40.4M |
| 4 |
Ferguson
FERG
|
$34M |
| 5 |
Apollo Global Management
APO
|
$32.5M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$91M |
| 2 |
Advanced Micro Devices
AMD
|
$53.5M |
| 3 |
Wynn Resorts
WYNN
|
$42.5M |
| 4 |
NVIDIA
NVDA
|
$38.5M |
| 5 |
Amazon
AMZN
|
$38.2M |
Sector Composition
| 1 | Healthcare | 68.4% |
| 2 | Technology | 8.43% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Communication Services | 5.73% |
| 5 | Industrials | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biohaven
BHVN
$1.63B
| $196M | 8.85% | 4,572,836 +567,236 | +14% | +$24.3M |
|
2
Arcellx
ACLX
$3.85B
| $135M | 6.11% | 2,435,974 -433,993 | -15% | -$24.1M |
|
3
Royalty Pharma
RPRX
$15.6B
| $109M | 4.94% | 3,887,702 -208,043 | -5% | -$5.84M |
|
|
4
Ultragenyx Pharmaceutical
RARE
$2.89B
| $102M | 4.6% | 2,126,306 +1,446,847 | +213% | +$69.2M |
|
5
Kura Oncology
KURA
$686M
| $99.9M | 4.52% | 6,946,230 -389,615 | -5% | -$5.6M |
|
6
EyePoint Pharmaceuticals
EYPT
$797M
| $93.8M | 4.24% | 4,056,847 +564,700 | +16% | +$13.1M |
|
|
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $83.5M | 3.78% | 1,165,948 -203,901 | -15% | -$14.6M |
|
8
Insmed
INSM
$28.8B
| $83.2M | 3.76% | 2,684,487 -761,847 | -22% | -$23.6M |
|
9
Meta Platforms (Facebook)
META
$1.86T
| $77.9M | 3.52% | 220,183 -60,462 | -22% | -$21.4M |
|
10
Microsoft
MSFT
$3.77T
| $60.9M | 2.75% | 161,924 -56,246 | -26% | -$21.2M |
|
|
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $58.1M | 2.63% | 5,346,119 +141,177 | +3% | +$1.53M |
|
|
12
Amazon
AMZN
$2.44T
| $55.9M | 2.53% | 368,089 -251,380 | -41% | -$38.2M |
|
13
89bio
ETNB
$1.34B
| $54.6M | 2.47% | 4,888,434 +2,194,030 | +81% | +$24.5M |
|
|
14
Apollo Global Management
APO
$77.9B
| $50.4M | 2.28% | 540,820 +348,920 | +182% | +$32.5M |
|
|
15
Advanced Micro Devices
AMD
$264B
| $49.2M | 2.22% | 333,468 -363,042 | -52% | -$53.5M |
|
16
GE Aerospace
GE
$292B
| $45.5M | 2.06% | 356,180 +5,211 | +1% | +$665K |
|
|
17
Goldman Sachs
GS
$226B
| $42.6M | 1.92% | +110,310 | New | +$42.6M |
|
|
18
TSMC
TSM
$1.2T
| $40.4M | 1.83% | +388,232 | New | +$40.4M |
|
19
Boston Scientific
BSX
$156B
| $40.1M | 1.81% | 694,101 +340,360 | +96% | +$19.7M |
|
20
Terns Pharmaceuticals
TERN
$609M
| $37.9M | 1.71% | 5,837,126 -204,784 | -3% | -$1.33M |
|
21
Fulcrum Therapeutics
FULC
$351M
| $37.3M | 1.68% | 5,518,881 -200,000 | -3% | -$1.35M |
|
22
Las Vegas Sands
LVS
$39.6B
| $36.3M | 1.64% | 738,163 +95,330 | +15% | +$4.69M |
|
|
23
Ferguson
FERG
$46.4B
| $34M | 1.54% | +176,090 | New | +$34M |
|
24
Oracle
ORCL
$635B
| $34M | 1.54% | 322,050 +66,739 | +26% | +$7.04M |
|
25
KalVista Pharmaceuticals
KALV
$678M
| $32.9M | 1.49% | 2,684,005 +263,154 | +11% | +$3.22M |
|